Quantum Biopharma $QNTM: Phase 1 MS Drug Trial Shows Promising...
Key Takeaways Quantum BioPharma has announced positive Phase 1 trial results for its multiple sclerosis drug, Lucid-21-302, which targets myelin repair without immune system suppression. The study demonstrated a strong...